Inhibiting or antagonizing glucagon: making progress in diabetes care.
about
Monogenic Diabetes: What It Teaches Us on the Common Forms of Type 1 and Type 2 Diabetes.Pharmacokinetics and pharmacodynamics of single and multiple doses of the glucagon receptor antagonist LGD-6972 in healthy subjects and subjects with type 2 diabetes mellitus.α-Glucosidase inhibitory activity and cytotoxic effects of some cyclic urea and carbamate derivatives.Glucagon actions on the kidney revisited: possible role in potassium homeostasis.Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.Unraveling the Regulation of Hepatic Metabolism by Insulin.Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes.Neutrophils Release Metalloproteinases during Adhesion in the Presence of Insulin, but Cathepsin G in the Presence of Glucagon.The PI3K/AKT pathway in obesity and type 2 diabetes
P2860
Q36960085-4033DF0F-9CDA-4629-90C3-4C9A3D219A77Q37561118-54F0AAA0-2905-41F2-A5BD-AE9C7951C7F6Q38720691-9F2FE857-2F23-410E-8FA0-8851B59530E7Q38838119-E73BCC7D-7D7C-4041-A15B-4124B9927E27Q39112475-7B99D0C9-F45B-4DBE-9F29-67102911C387Q39246859-8769EA59-75C4-4C3D-9911-47B1308658B0Q47625288-12238106-A020-4838-B360-07D59D5CE167Q55385577-1F6BD3A9-58E5-4E58-8336-2D4CFD769E64Q58798256-E39DBBFD-4663-4331-AD90-6B449B265151
P2860
Inhibiting or antagonizing glucagon: making progress in diabetes care.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Inhibiting or antagonizing glucagon: making progress in diabetes care.
@en
type
label
Inhibiting or antagonizing glucagon: making progress in diabetes care.
@en
prefLabel
Inhibiting or antagonizing glucagon: making progress in diabetes care.
@en
P2093
P2860
P356
P1476
Inhibiting or antagonizing glucagon: making progress in diabetes care.
@en
P2093
A J Scheen
P J Lefèbvre
P2860
P304
P356
10.1111/DOM.12480
P577
2015-04-29T00:00:00Z